4//SEC Filing
PRYGOCKI MARK A SR 4
Accession 0000899243-21-048213
CIK 0001817944other
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 7:03 PM ET
Size
7.5 KB
Accession
0000899243-21-048213
Insider Transaction Report
Form 4
PRYGOCKI MARK A SR
Director
Transactions
- Award
Common Stock
2021-12-12+3,844→ 3,844 total - Award
Stock Option (Right to Buy)
2021-12-12+9,610→ 9,610 totalExercise: $4.78Exp: 2031-12-11→ Common Stock (9,610 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 3,844 shares on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date.
- [F2]These options were granted under the 2021 Plan and vest in equal annual installments over a period of three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting.
Documents
Issuer
Clarus Therapeutics Holdings, Inc.
CIK 0001817944
Entity typeother
Related Parties
1- filerCIK 0001257544
Filing Metadata
- Form type
- 4
- Filed
- Dec 13, 7:00 PM ET
- Accepted
- Dec 14, 7:03 PM ET
- Size
- 7.5 KB